Studying the blood trough level of tacrolimus on patients after kidney transplant at the uronephreulogical department, Bach Mai Hospital, Vietnam

Tacrolimus, a calcineurin inhibitor, is a first-choice drug for the anti-rejection treatment regimen after kidney transplantation. The daily adjusted Tacrolimus dose by therapeutic drug monitoring is essential for patients to achieve optimal effects and minimize complications.